drugset

drugset / Trial / NCT01194375

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

NCT01194375 ↗

Phase 2 Completed 180 enrolled Dow Pharmaceutical Sciences

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of IDP-107 versus placebo in treating patients with acne vulgaris.

Timeline

Start: 2010-09
Primary completion: 2011-12
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IDP-107	Unknown	—	—

Indications